A study to assess the pulmonary distribution of Budesonide, Glycopyrronium and Formoterol Fumarate

Trial Identifier: D5980C00007
Sponsor: AstraZeneca
NCTID:: NCT03740373
Start Date: September 2018
Primary Completion Date: October 2018
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
English Translation

Trial Locations

Country Location
United Kingdom Pentrebach, United Kingdom, CF48 4DR